MiniMed Group, Inc. Common Stock (MMED) - Total Liabilities
Based on the latest financial reports, MiniMed Group, Inc. Common Stock (MMED) has total liabilities worth $1.10 Billion USD as of July 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See MiniMed Group, Inc. Common Stock current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
MiniMed Group, Inc. Common Stock - Total Liabilities Trend (2024–2026)
This chart illustrates how MiniMed Group, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see MMED current and non-current assets.
MiniMed Group, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of MiniMed Group, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Open Text Corp
NASDAQ:OTEX
|
USA | $9.52 Billion |
|
Amorepacific Corp. (New)
KO:090430
|
Korea | ₩1.52 Trillion |
|
37 Interactive Entertainment Network Technology Group Co Ltd
SHE:002555
|
China | CN¥7.81 Billion |
|
Remgro Ltd
JSE:REM
|
South Africa | ZAC20.43 Billion |
|
Ultrapar Participações S.A
F:UGR
|
Germany | €31.62 Billion |
|
Ferrotec (Anhui) Technology Development Co. Ltd. A
SHE:301297
|
China | CN¥1.36 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr29.11 Billion |
|
Strathcona Resources Ltd.
TO:SCR
|
Canada | CA$4.41 Billion |
Liability Composition Analysis (2024–2026)
This chart breaks down MiniMed Group, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MiniMed Group, Inc. Common Stock (MMED) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.81 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.30 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how MiniMed Group, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for MiniMed Group, Inc. Common Stock (2024–2026)
The table below shows the annual total liabilities of MiniMed Group, Inc. Common Stock from 2024 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-04-30 | $1.02 Billion | +17.13% |
| 2025-04-30 | $870.00 Million | +34.67% |
| 2024-04-30 | $646.00 Million | -- |
About MiniMed Group, Inc. Common Stock
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, such as insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin the… Read more